News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

VSM MedTech Ltd. Announces MEG Distribution Strategy For Asian Market International Acceptance Of Brain Imaging Technology Grows (CCN Newswire)...CTF`s proprietary leading edge technology for MEG (Magnetoencephalography), which gives precise information on the brain`s function including touch, speech, vision, hearing and motor skills.......This technology is used in pre-surgical assessment of tumors, epilepsy tissue and localization of trauma, cognitive and psychological disorders....- May 14 9:28 AM ET


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/ccn/010514/ssgqtezeba40bxsyhbustg.html


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740